EPRONTIA™已被批准作为单一疗法,用于治疗2岁及以上患者的部分发作或原发性全身强直-阵挛发作;作为辅助疗法,用...查看全文
美港电讯APP2021-08-06 16:28
$Eton Pharmaceuticals(ETON)$ 盘前涨10.4%,美国食品药品监督管理局(FDA)今日将审核是否批准Eton Pharmaceuticals治疗癫痫的口服新药。(来自美港电讯APP)查看全文
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-020809 Size: 4 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-21-020195 Act: 34 Size: 331 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-21-020041 Act: 34 Size: 5 MB 网页链接
$Eton Pharmaceuticals(ETON)$ 内部交易: 2021-08-06,10% Owner,Opaleye Management Inc. ,卖出,345000普通股, $5.84
$Eton Pharmaceuticals(ETON)$ 内部交易: 2021-08-05,10% Owner,Opaleye Management Inc. ,卖出,155500普通股, $5.85
$Eton Pharmaceuticals(ETON)$ 内部交易: 2021-08-04,10% Owner,Opaleye Management Inc. ,卖出,104000普通股, $5.75
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-018955 Size: 15 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, item 8.01 Accession Number: 0001493152-21-018932 Act: 34 Size: 29 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, item 5.07 Accession Number: 0001493152-21-015005 Act: 34 Size: 44 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-014742 Size: 7 KB 网页链接